Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology: It takes 2 to tango On-Demand Webinar 根据机制性模型发现和开发用于免疫肿瘤学的双特异性抗体:探戈需要 2 人配合 More than 50 bispecific antibodies are in oncology clinical development with a large diversity in…Certara2020 年 12 月 2 日
Getting Real with RWE Press Coverage Getting Real with RWE By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…Certara2020 年 11 月 20 日
Regulatory submissions and transactions with Health Canada Blog Regulatory submissions and transactions with Health Canada By Robert Labriola We’ve seen recent trends and activity with regards to pharmaceutical regulatory submissions…Certara2020 年 11 月 19 日
Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters Publication Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters Certara2020 年 11 月 13 日
How PBPK Modeling Can Replace Drug-Drug Interaction Studies Press Coverage How PBPK Modeling Can Replace Drug-Drug Interaction Studies Patients often take more than one drug at a time, especially elderly patients and those…Certara2020 年 11 月 12 日
Certara Opens New China Office in Shanghai Press Release Certara Opens New China Office in Shanghai Office will support rapid growth and collaboration with customers in China to accelerate biopharmaceutical R&D …Certara2020 年 11 月 9 日
Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics Publication Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics Certara2020 年 10 月 30 日
The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal White Paper COVID-19 对利益相关者参与和价值传播的影响:准备迎接 New Normal Certara2020 年 10 月 28 日